comparemela.com
Home
Live Updates
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance : comparemela.com
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2022. Second-quarter sales of $11.3 billion...
Related Keywords
China ,
Robertb Ford ,
,
Linkedin ,
Drug Administration ,
Core Laboratory Diagnostics ,
Sales In Core Laboratory ,
European Union Medical Device ,
Facebook ,
Abbott Laboratories ,
Core Laboratory ,
Pediatric Nutrition ,
Adult Nutrition ,
Molecular Diagnostics ,
Emerging Markets ,
Medical Devices ,
Diabetes Care ,
Freestyle Libre ,
Aristocrats Index ,
Investor Relations ,
Private Securities Litigation Reform Act ,
Caution Concerning Forward Looking ,
Annual Report ,
Abbott Diabetes ,
Consolidated Statement ,
Quarter Ended June ,
Operating Cost ,
Earnings Excluding Specified Items ,
Common Share ,
Specified Items ,
Common Shares ,
Dilutive Common Stock Options ,
Diluted Earnings ,
Half Ended June ,
Financial Information ,
Gross Margin ,
European Union ,
Medical Device ,
Vitro Diagnostics Medical Device ,
Abbott ,
Household ,
Onsumer Amp Cosmetics ,
Retail ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Earnings Forecasts Amp Projections ,
Earnings ,
comparemela.com © 2020. All Rights Reserved.